|Bid||6.11 x 1100|
|Ask||6.30 x 900|
|Day's Range||6.13 - 6.44|
|52 Week Range||3.50 - 12.01|
|Beta (5Y Monthly)||1.70|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug. 04, 2020 - Aug. 10, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||12.67|
NEW YORK, NY / ACCESSWIRE / June 5, 2020 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Evolent Health, Inc. ("Evolent" or "the Company") ...
Investors need to pay close attention to Evolent Health (EVH) stock based on the movements in the options market lately.
Shares of Evolent Health (NYSE: EVH) closed down 23% on Monday because the healthcare company's partner, Passport Health Plan, didn't get its Medicaid contract with the state of Kentucky renewed for 2021. The significant portion of revenue we derive from our largest partners, and the potential loss, termination or renegotiation of our relationship or contract with Passport or another significant partner, or multiple partners in the aggregate. Since the contract runs through the end of the year, this year's revenue won't be affected, and Evolent Health reiterated its 2020 revenue guidance of $935 million to $985 million.
It's been a good week for Evolent Health, Inc. (NYSE:EVH) shareholders, because the company has just released its...
Shares of Evolent Health (NYSE: EVH) were up 7.6% at 1:12 p.m. EDT on Friday following the release of first-quarter results after the closing bell on Thursday. The healthcare company, which provides clinical and administrative solutions to health insurers and other payers, basically met its revenue goal for the quarter and kept its 2020 revenue guidance the same. Evolent Health was able to increase revenue by 25% year over year to $247.3 million in the first quarter.
Evolent Health, Inc. (NYSE:EVH) shareholders should be happy to see the share price up 13% in the last month. But that...
SAN DIEGO, March 24, 2020 -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in NYSE: EVH shares. Investors, who purchased shares.
It's been a mediocre week for Evolent Health, Inc. (NYSE:EVH) shareholders, with the stock dropping 16% to US$9.75 in...
If you're interested in Evolent Health, Inc. (NYSE:EVH), then you might want to consider its beta (a measure of share...
Potential Evolent Health, Inc. (NYSE:EVH) shareholders may wish to note that the Co-Founder, Frank Williams, recently...
Evolent Health (EVH) delivered earnings and revenue surprises of 40.00% and 1.31%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NEW YORK, NY / ACCESSWIRE / October 7, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a ...
LOS ANGELES, CA / ACCESSWIRE / October 7, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Evolent Health, Inc. ("Evolent" or "the Company") (NYSE:EVH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between March 3, 2017 and May 28, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before October 7, 2019.
NEW YORK, NY / ACCESSWIRE / October 7, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment.
NEW YORK, NY / ACCESSWIRE / October 7, 2019 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Evolent Health, Inc. ("Evolent" or the "Company") (NYSE:EVH) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Evolent securities between March 3, 2017 and May 28, 2019, both dates inclusive. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.